RA Patient with a History of Malignancy

EXPERT VIDEOIBECCME

CME Information

Support Statement: This activity is supported by educational grants from Bristol-Myers Squibb, Lilly, and Pfizer.

Target Audience: The intended audience for this activity is rheumatologists, rheumatology nurses, and other health care professionals involved in the treatment of patients with rheumatoid arthritis (RA).

Learning Objectives: Upon successful completion of this educational activity, participants should be better able to examine the immunopathogenesis and therapeutic landscape of RA and allied conditions, as well as strategies to mitigate risk from biologic and immune-based agents.

Activity Chair:
Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Director of the R.J. Fasenmyer Center for Clinical Immunology
Cleveland Clinic
Cleveland, OH

Faculty:
Jonathan Kay, MD
Timothy S. and Elaine L. Peterson Chair in Rheumatology
Professor of Medicine
University of Massachusetts Medical School
University of Massachusetts Memorial Medical Center
Worcester, MA

John Tesser, MD
Clinical Lecturer, University of Arizona Health Sciences Center
Adjunct Clinical Professor, Midwestern University College of Health Sciences
Arizona Arthritis & Rheumatology Associates, P.C.
Phoenix, AZ

Reviewers:
Kevin D. Deane, MD, PhD
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP

This enduring material is approved for 1 year from the date of original release, September 6, 2016 to September 5, 2017.

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

Steering Committee and Faculty report the following relationship(s):
Leonard H. Calabrese, DO
Consulting Fee: GlaxoSmithKline, Janssen, Pfizer, Sanofi
Speakers Bureau: AbbVie, Bristol-Myers Squibb, Crescendo, Genentech, Janssen

Joseph E. Craft, MD
Non-CME Services Fees: Bristol-Myers Squibb, MedImmune

John J. Cush, MD
Consulting Fee: AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Janssen, Lilly, Novartis, Pfizer, UCB Clinical Investigator: AbbVie, AstraZeneca, Celgene, Janssen, Novartis, Pfizer

Allan Gibofsky, MD, JD, MACR, FACP, FCLM
Consulting Fee: AbbVie, Celgene, Iroko Pharmaceuticals, Pfizer, Takeda
Speakers Bureau: AbbVie, Celgene, Iroko Pharmaceuticals, Pfizer
Ownership Interest: AbbVie, Amgen, Bristol-Myers Squibb, Johnson & Johnson, Pfizer, Regeneron

Jonathan Kay, MD
Consulting Fee: AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim GMbH, Bristol-Myers Squibb, Elil-Lilly, Epirus Biopharmaceuticals, Genentech Inc., GlaxoSmithKline, Hospira, Janssen, Merck, Myriad, Novartis, Roche, Pfizer, Samsung Bioepis, Sandoz, UCB
Contract Research: (Paid to Institution) AbbVie, Genentech, Eli-Lilly, Pfizer, Roche

Elizabeth Kirchner, CNP, MSN
Consulting Fee: Pfizer, Sanofi
Speakers Bureau: Crescendo Bioscience

William F.C. Rigby, MD
Consulting Fee: Bristol-Myers Squibb, Lilly, Pfizer, Roche
Non-CME Services Fees: Bristol-Myers Squibb
Contracted Research: Amgen, Bristol-Myers Squibb, Pfizer, Roche

Sergio Schwartzman, MD
Consulting Fee: AbbVie, Crescendo, Epirus, Genentech, Hospira, Janssen, Novartis, Pfizer, Regeneron
Speakers Bureau: AbbVie, Crescendo, Genentech, Hospira, Janssen, Novartis, Pfizer
Ownership Interest: Amgen, Gilead, Medtronic, Pfizer
Board Member: Discus-Analytics National Psoriasis Foundation Scientific Advisory Board Member: Bioscience, Crescendo

Gregg Silverman, MD
Consulting Fee: Bristol-Myers Squibb, Genentech
Speakers Bureau: Genentech

John Tesser, MD
Consulting Fee: Bristol-Myers Squibb, Lilly, Pfizer
Speakers Bureau: Bristol-Myers Squibb, Pfizer
Contracted Research: Bristol-Myers Squibb, Lilly, Pfizer

Reviewers report the following relationship(s):
Kevin Deane, MD
Consulting Fee: Janssen
Honoraria: Medscape

Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.